Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
If it works well enough, this would give doctors a lower-dose option for patients who respond without needing the maximum, similar to how many tirzepatide patients do well on 10 mg without going to 15 mg
Walker says, GLP-1 RAs are not an FDA-cleared treatment for dermatologic use
Research and Regulatory Status Approved Use (Native IGF-1): The native recombinant human IGF-1 (Mecasermin) is FDA-approved for growth failure in children with severe IGF-1 deficiency
As a result, multiple states are terminating (or seriously considering terminating) GLP-1 weight loss drug coverage for state employees
COVERAGE VARIES BY PLAN Medicare Advantage Wegovy Coverage Medicare Advantage (Part C) plans with prescription drug coverage (MA-PD) must follow the same federal exclusion for weight loss drugs, but coverage for the CV indication varies significantly by plan
